Immune checkpoint inhibitors in osteosarcoma: A hopeful and challenging future
Osteosarcoma (OS), the most common malignant tumor in the musculoskeletal system, mainly occurs in adolescents. OS results in high mortality and disability rates due to a fatal metastatic tendency and subsequent iatrogenic damage caused by surgery, radiotherapy and chemotherapy. Recently, immunother...
Saved in:
Main Authors: | , , , , |
---|---|
格式: | Revisão |
語言: | 英语 |
出版: |
2022
|
在線閱讀: | https://doi.org/10.3389/fphar.2022.1031527 https://www.frontiersin.org/articles/10.3389/fphar.2022.1031527/pdf |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|